Trial · NCT04291508
Adverse events272
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 272
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Acute Blood Loss Anemia | Blood and lymphatic system disorders | IV Acetaminophen-Active | 1 | 227 | |
| other | Acute Blood Loss Anemia | Blood and lymphatic system disorders | IV Vitamin C-Active | 0 | 40 | |
| other | Acute Blood Loss Anemia | Blood and lymphatic system disorders | Acetaminophen-Placebo | 0 | 199 | |
| other | Acute Blood Loss Anemia | Blood and lymphatic system disorders | Vitamin C-Placebo | 0 | 21 | |
| other | Paroxysmal Atrial Fibrillation | Cardiac disorders | IV Acetaminophen-Active | 1 | 227 | |
| other | Paroxysmal Atrial Fibrillation | Cardiac disorders | IV Vitamin C-Active | 0 | 40 | |
| other | Paroxysmal Atrial Fibrillation | Cardiac disorders | Acetaminophen-Placebo | 0 | 199 | |
| other | Paroxysmal Atrial Fibrillation | Cardiac disorders | Vitamin C-Placebo | 0 | 21 | |
| other | Diabetes Mellitus | Endocrine disorders | IV Acetaminophen-Active | 1 | 227 | |
| other | Diabetes Mellitus | Endocrine disorders | IV Vitamin C-Active | 0 | 40 | |
| other | Diabetes Mellitus | Endocrine disorders | Acetaminophen-Placebo | 0 | 199 | |
| other | Diabetes Mellitus | Endocrine disorders | Vitamin C-Placebo | 0 | 21 | |
| other | Dyspepsia | Gastrointestinal disorders | IV Acetaminophen-Active | 1 | 227 | |
| other | Dyspepsia | Gastrointestinal disorders | IV Vitamin C-Active | 0 | 40 | |
| other | Dyspepsia | Gastrointestinal disorders | Acetaminophen-Placebo | 0 | 199 | |
| other | Dyspepsia | Gastrointestinal disorders | Vitamin C-Placebo | 0 | 21 | |
| other | Hepatocellular Damage | Hepatobiliary disorders | IV Acetaminophen-Active | 1 | 227 | |
| other | Hepatocellular Damage | Hepatobiliary disorders | IV Vitamin C-Active | 0 | 40 | |
| other | Hepatocellular Damage | Hepatobiliary disorders | Acetaminophen-Placebo | 0 | 199 | |
| other | Hepatocellular Damage | Hepatobiliary disorders | Vitamin C-Placebo | 0 | 21 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04291508/events